Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis: A systematic literature review.

Abstract:

OBJECTIVE:We investigated the effectiveness of rituximab (an anti-CD20 monoclonal antibody) in patients with eosinophilic granulomatosis with polyangiitis (EGPA). METHODS:We performed a systematic literature review from the inception dates until July 20, 2020 for articles reporting rituximab administration to treat EGPA. RESULTS:We identified a total of 171 patients; most of the patients had refractory or relapsing disease, whereas 14 patients were newly diagnosed with EGPA. Rituximab was used for induction therapy in all patients and administered as four infusions of 375 mg/m2/week, or two infusions of 1000 mg, given 2 weeks apart. The observation period was 6-36 months after rituximab initiation. The remission rates (defined as a Birmingham Vasculitis Activity Score of 0 along with low dose glucocorticoid) were 36 to 100%. Anti-neutrophil cytoplasmic antibody (ANCA)-positive patients tended to respond better to rituximab than ANCA-negative patients. All studies reported the successful reduction of glucocorticoid dose after rituximab treatment. The median glucocorticoid dose at rituximab initiation was 12.5-60 mg/day, which was successfully reduced to 0-8.5 mg/day after rituximab treatment. Scheduled rituximab maintenance treatment significantly reduced the relapse rates as compared to rituximab administered on demand. No new safety signal was reported. CONCLUSION:Rituximab effectively induced and sustained remission and reduced glucocorticoid dose in patients with newly diagnosed or relapsing and refractory EGPA; it also showed potentially greater benefit in ANCA-positive patients than in ANCA-negative patients.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

Akiyama M,Kaneko Y,Takeuchi T

doi

10.1016/j.autrev.2020.102737

subject

Has Abstract

pub_date

2021-02-01 00:00:00

pages

102737

issue

2

eissn

1568-9972

issn

1873-0183

pii

S1568-9972(20)30318-9

journal_volume

20

pub_type

杂志文章,评审
  • The future landscape of biosimilars in rheumatology: Where we are where we are going.

    abstract:INTRODUCTION:The upcoming of biosimilars in rheumatic diseases have generated considerable interest throughout the past five years among pharmaceutical industries and regulatory agencies, their development is associated with considerable variation and heterogeneity on the variable requirements for license and marketing...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.09.005

    authors: Scheinberg M,Azevedo V

    更新日期:2019-02-01 00:00:00

  • Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndrome.

    abstract:BACKGROUND:Long-term anticoagulation is recommended in antiphospholipid syndrome with thrombosis in order to prevent recurrences. While the current mainstay relies on vitamin K antagonists, their long-term maintenance may remain challenging. OBJECTIVES:To report on the safety and the efficacy of oral direct inhibitors...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.03.007

    authors: Noel N,Dutasta F,Costedoat-Chalumeau N,Bienvenu B,Mariette X,Geffray L,Sene D,Chaidi RB,Michot JM,Fain O,Darnige L,Ankri A,Cacoub P,Piette JC,Saadoun D

    更新日期:2015-08-01 00:00:00

  • Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis.

    abstract::Autoimmune responses and inflammation are involved in the excess cardiovascular risk observed in patients with systemic inflammatory diseases. Autoimmune myocarditis is a presentation of an inflammatory reaction of the heart during the course of autoimmune disorders, with most cases seen in systemic lupus erythematosu...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.05.005

    authors: Mavrogeni S,Dimitroulas T,Kitas GD

    更新日期:2012-12-01 00:00:00

  • The role of innate immune responses in autoimmune disease development.

    abstract::Autoimmune diseases are systemic or organ-specific disorders that are the result of an attack of the immune system against the body's own tissue. Development of autoimmune disease is generally avoided by distinct mechanisms that silence adaptive self-reactive T or B cells. The innate immune system is critically involv...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.12.019

    authors: Waldner H

    更新日期:2009-03-01 00:00:00

  • Exosomes: Effectual players in rheumatoid arthritis.

    abstract::Rheumatoid arthritis is a well-known chronic inflammatory joint disorder. It encompasses systemic inflammation, autoimmunity and development of several joint abnormalities leading to the lifelong disability and increased mortality. Exosomes are nano-sized (30-100 nm) mammalian extracellular particles with essential pr...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2020.102511

    authors: Tavasolian F,Moghaddam AS,Rohani F,Abdollahi E,Janzamin E,Momtazi-Borojeni AA,Moallem SA,Jamialahmadi T,Sahebkar A

    更新日期:2020-06-01 00:00:00

  • Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity.

    abstract::Since many years immunologists have being tried to answer the tantalizing enigma of immunological tolerance. Complex mechanisms in both thymus (central tolerance) and peripheral lymphoid organs (peripheral tolerance) underly lymphocyte tolerance and its maintenance. The genesis of autoimmunity involves environmental a...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.08.019

    authors: Fierabracci A

    更新日期:2011-01-01 00:00:00

  • COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?

    abstract::The severe form of COVID-19 share several clinical and laboratory features with four entities gathered under the term "hyperferritinemic syndromes" and including macrophage activation syndrome (MAS), adult-onset Still's disease (AOSD), catastrophic anti-phospholipid syndrome (CAPS) and septic shock. COVID-19 systemic ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2020.102573

    authors: Colafrancesco S,Alessandri C,Conti F,Priori R

    更新日期:2020-07-01 00:00:00

  • Rheumatoid arthritis (RA) and cardiovascular disease.

    abstract::Patients with rheumatoid arthritis (RA) suffer cardiovascular events 1.5-2 fold than the general population, and cardiovascular (CV) events are leading cause of death in patients with RA. It is known that patients with RA have endothelial dysfunction, related with impaired function of endothelial progenitor cells (EPC...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,收录出版,评审

    doi:10.1016/j.autrev.2019.05.005

    authors: Blum A,Adawi M

    更新日期:2019-07-01 00:00:00

  • Insights into IL-37, the role in autoimmune diseases.

    abstract::Autoimmune diseases are characterized by the impaired function and the destruction of tissues that are caused by an immune response in which aberrant antibodies are generated and attack the body's own cells and tissues. Interleukin (IL) -37, a new member of the IL-1 family, broadly reduces innate inflammation as well ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.08.006

    authors: Xu WD,Zhao Y,Liu Y

    更新日期:2015-12-01 00:00:00

  • The role of gender and organ specific autoimmunity.

    abstract::Autoimmunity is influenced by multiple factors including gender and sex hormones. A definite female predominance is found in many autoimmune diseases. Gender is also associated with differences in clinical presentation, onset, progression and outcome of autoimmune diseases. Sex hormones might influence the target orga...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.001

    authors: Nussinovitch U,Shoenfeld Y

    更新日期:2012-05-01 00:00:00

  • Autoimmune and proinflammatory activity of oxidized immunoglobulins.

    abstract:AIMS:Oxidation reactions can modify protein activity or specificity. Recently, a novel redox-reactive family of autoantibodies was described, which indicated involvement of altered antibodies (beside altered antigens) into autoimmune reactions. The aim of our study was to determine the binding capacity alterations of e...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2008.04.005

    authors: Omersel J,Jurgec I,Cucnik S,Kveder T,Rozman B,Sodin-Semrl S,Bozic B

    更新日期:2008-07-01 00:00:00

  • Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review.

    abstract::TNF-alpha is a crucial cytokine in the establishment and maintenance of inflammation in multiple autoimmune and non-autoimmune disorders. A number of large placebo-controlled trials have shown that infliximab, a chimeric monoclonal antibody against TNF-alpha, is effective and well-tolerated in patients with Crohn's di...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2004.08.004

    authors: Atzeni F,Sarzi-Puttini P,Doria A,Iaccarino L,Capsoni F

    更新日期:2005-03-01 00:00:00

  • Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases.

    abstract::Heat-shock protein (Hsp) family is made up of heterogeneous proteins of which Hsp60 members are the most studied. It is now generally admitted that Hsp60 is not only a mitochondrial component but can be localized on the membrane cell surface. Considered as a signal danger following infections, Hsp60 can induce the pro...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.01.012

    authors: Alard JE,Dueymes M,Youinou P,Jamin C

    更新日期:2007-08-01 00:00:00

  • Modulation of autoimmunity with artificial peptides.

    abstract::The loss of immune tolerance to self antigens leads to the development of autoimmune responses. Since self antigens are often multiple and/or their sequences may be known, one approach to restore immune tolerance uses synthetic artificial peptides that interfere or compete with self peptides in the networks of cellula...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.08.017

    authors: La Cava A

    更新日期:2010-11-01 00:00:00

  • Benefits and burden of the maternally-mediated immunological imprinting.

    abstract::The ontogenetic development of both the immune and the nervous system entirely depend on external environmental signals that induce a lifelong learning process. The resulting collective immunological knowledge about the external world is transmitted in an epi-genetic fashion to the offspring, but only from the materna...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.12.005

    authors: Lemke H,Tanasa RI,Trad A,Lange H

    更新日期:2009-03-01 00:00:00

  • Tight control applied to the biological therapy of rheumatoid arthritis.

    abstract::In the last decade, treatment strategies for rheumatoid arthritis (RA) have included the early use of disease-modifying anti-rheumatic drugs, since prompt suppression of disease activity is associated with a reduction in radiological damage. This strategy has now been incorporated into the broader concept of "tight co...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.11.010

    authors: Epis OM,Giacomelli L,Deidda S,Bruschi E

    更新日期:2013-06-01 00:00:00

  • Survivin in autoimmune diseases.

    abstract::Survivin is a protein functionally important for cell division, apoptosis, and possibly, for micro-RNA biogenesis. It is an established marker of malignant cell transformation. In non-malignant conditions, the unique properties of survivin make it indispensable for homeostasis of the immune system. Indeed, it is requi...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.05.016

    authors: Gravina G,Wasén C,Garcia-Bonete MJ,Turkkila M,Erlandsson MC,Töyrä Silfverswärd S,Brisslert M,Pullerits R,Andersson KM,Katona G,Bokarewa MI

    更新日期:2017-08-01 00:00:00

  • The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials.

    abstract::To date, no immunomodulatory drug has proved efficacious in primary Sjögren's syndrome (pSS). In pSS, difficulties in drug efficacy assessment is related to the large spectrum of clinical involvements (glandular/extraglandular involvement), to the lack of correlation between symptoms of dryness and glandular function ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2018.12.008

    authors: Felten R,Scher F,Sibilia J,Gottenberg JE,Arnaud L

    更新日期:2019-06-01 00:00:00

  • International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholip

    abstract::Autoimmune diseases are a complex set of diseases characterized by immune system activation and, although many progresses have been done in the last 15years, several unmet needs in the management of these patients may be still identified. Recently, a panel of international Experts, divided in different working groups ...

    journal_title:Autoimmunity reviews

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1016/j.autrev.2017.07.012

    authors: Giacomelli R,Afeltra A,Alunno A,Baldini C,Bartoloni-Bocci E,Berardicurti O,Carubbi F,Cauli A,Cervera R,Ciccia F,Cipriani P,Conti F,De Vita S,Di Benedetto P,Doria A,Drosos AA,Favalli EG,Gandolfo S,Gatto M,Grembiale R

    更新日期:2017-09-01 00:00:00

  • Menopause in patients with autoimmune diseases.

    abstract::Menopause represents a time of significant clinical and hormonal change. Given the incompletely understood interrelationship between gonadal hormones and the immune system, it is possible that menopause may affect, or be affected by, the presence of autoimmune disease. Menopause has significant effects on a number of ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.006

    authors: Sammaritano LR

    更新日期:2012-05-01 00:00:00

  • Pulmonary manifestations in antiphospholipid syndrome.

    abstract::Pulmonary manifestations in antiphospholipid syndrome (APS) are relatively rare compared to other clinical signs of this disease. However, pulmonary microthrombosis is among the most frequent arterial complications of APS. Timely diagnosis of pulmonary manifestations is required due both to their severity and to the h...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.02.002

    authors: Stojanovich L

    更新日期:2006-05-01 00:00:00

  • Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC).

    abstract::Autotaxin (ATX) is a 125-kD type II ectonucleotide pyrophosphatase/phosphodiesterase (ENPP2 or NPP2) originally discovered as an unknown "autocrine motility factor" in human melanoma cells. In addition to its pyrophosphatase/phosphodiesterase activities ATX has lysophospholipase D (lysoPLD) activity, catalyzing the co...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.03.019

    authors: Sun Y,Zhang W,Evans JF,Floreani A,Zou Z,Nishio Y,Qi R,Leung PS,Bowlus CL,Gershwin ME

    更新日期:2016-08-01 00:00:00

  • Cardiomyopathy - An approach to the autoimmune background.

    abstract::Autoimmunity is increasingly accepted as the origin or amplifier of various diseases. In contrast to classic autoantibodies (AABs), which induce immune responses resulting in the destruction of the affected tissue, an additional class of AABs is directed against G-protein-coupled receptors (GPCRs; GPCR-AABs). GPCR-AAB...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.01.012

    authors: Becker NP,Müller J,Göttel P,Wallukat G,Schimke I

    更新日期:2017-03-01 00:00:00

  • Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age?

    abstract::Autoimmune rheumatic diseases (ARD) are prevalent in women during their childbearing age. For their treatment, high doses of corticosteroid (CS) for long-term periods are often required, increasing the risk of bone loss. According to recent guidelines, bisphosphonates (BP) should be used as first line treatment to pre...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.03.002

    authors: Losada I,Sartori L,Di Gianantonio E,Zen M,Clementi M,Doria A

    更新日期:2010-06-01 00:00:00

  • Coeliac disease.

    abstract::Coeliac disease is a gluten-sensitive enteropathy characterized by villous atrophy, hyperplastic crypts and increased numbers of intraepithelial lymphocytes which are reversed by gluten withdrawal. Diverse autoimmune disorders are frequently associated with the disease, and patients also carry an increased risk of gas...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.06.013

    authors: Periolo N,Cherñavsky AC

    更新日期:2006-03-01 00:00:00

  • The geoepidemiology of autoimmune intestinal diseases.

    abstract::Inflammatory bowel diseases (IBD) are chronic diseases of the intestinal tract which principally are composed of ulcerative colitis (UC) and Crohn's disease (CD). The prevalence and incidence of both forms of IBD have historically been higher in developed countries with decreasing North-South gradient. However, more r...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.11.008

    authors: Logan I,Bowlus CL

    更新日期:2010-03-01 00:00:00

  • Kawasaki disease: current aspects on aetiopathogenesis and therapeutic management.

    abstract::Kawasaki disease (KD) is a vasculitis that affects mainly children of 6 months to 4 years old. It is important to be early recognised so as to limit the inflammatory cascade that may lead to aneurysmatic dilatations of coronary arteries. The causative agent of KD has not been still indentified and the aetiopathogeneti...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.04.005

    authors: Alexoudi I,Kanakis M,Kapsimali V,Vaiopoulos G

    更新日期:2011-07-01 00:00:00

  • Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis.

    abstract::Recurrent pericarditis is a frequent and troublesome complication of acute pericarditis. Aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine are the mainstay of therapy but few data is available on second-line treatment. We retrospectively analyzed 13 patients, 7 females (54%), median age 40 years...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2019.04.001

    authors: Peiffer-Smadja N,Domont F,Saadoun D,Cacoub P

    更新日期:2019-06-01 00:00:00

  • Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia.

    abstract::Mixed cryoglobulinemia (MC) is an immunological disorder characterized by immune-complex-mediated systemic vasculitis involving small vessels, which may present with renal, cutaneous, rheumatologic, and/or neurological manifestations. Until recently, the possible appearance of anti-neuronal autoantibodies in periphera...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.07.027

    authors: Alpa M,Ferrero B,Cavallo R,Naretto C,Menegatti E,Di Simone D,Napoli F,La Grotta R,Rossi D,Baldovino S,Sena LM,Roccatello D

    更新日期:2008-10-01 00:00:00

  • Catastrophic antiphospholipid (Asherson's) syndrome and genetic thrombophilic disorders in obstetrics.

    abstract::Catastrophic antiphospholipid syndrome (CAPS) (Asherson's Syndrome), is a life-threatening condition characterized by a rapidly progressive thromboses resulting in a multiorgan dysfunction syndrome (MODS), evidence of systemic inflammatory response syndrome (SIRS) in the presence of antiphospholipid antibodies. CAPS d...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.06.011

    authors: Makatsariya A,Asherson RA,Bitsadze V,Baimuradova S,Akinshina S

    更新日期:2006-12-01 00:00:00